Strategic focus on India aims to make the Swoop® portable MR brain imaging system commercially available in a vast and underserved MRI market
Profit Before Tax is Rs. 220 crore, registering a commendable 64% growth
The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
According to IQVIATM sales data for the 12-month period ending March 2024, the Combigan Ophthalmic Solution, 0.2%|0.5% market achieved annual sales of approximately $290.0 million
35,000 doctors from across India pledged their support for the initiative to raise awareness about cardiovascular diseases
The company has posted net profit of Rs.357.7 crores for the Financial Year ended March 31, 2024
ORACEA is a trademark of Galderma Holdings, S.A.
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
Subscribe To Our Newsletter & Stay Updated
